Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $835.7350 (1.81%) ($835.7350 - $842.0200) on Wed. Dec. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.08% (three month average) | RSI | 78 | Latest Price | $835.7350(1.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 1.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) SDY(53%) IBB(51%) SPLV(48%) XLV(48%) XLU(45%) | Factors Impacting REGN price | REGN will decline at least -0.54% in a week (0% probabilities). VXX(-36%) ONLN(-36%) USO(-35%) XLE(-28%) UNG(-28%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.54% (StdDev 1.08%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $823.41(1.5%) | 10 Day Moving Average | $812.9(2.81%) | 20 Day Moving Average | $806.54(3.62%) | To recent high | -1.2% | To recent low | 7.8% | Market Cap | $88.612b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |